As of 2024-12-15, the Relative Valuation of Immunovant Inc (IMVT) is (49.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.28 USD, the upside of Immunovant Inc based on Relative Valuation is -287.6%.
The range of the Relative Valuation is (45.60) - (42.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 31.0x | 25.8x |
| Forward P/E multiples | 18.7x - 19.2x | 19.0x |
| Fair Price | (45.60) - (42.30) | (49.29) |
| Upside | -273.5% - -260.9% | -287.6% |
| Date | P/E |
| 2024-12-11 | -13.00 |
| 2024-12-10 | -13.15 |
| 2024-12-09 | -13.04 |
| 2024-12-06 | -13.01 |
| 2024-12-05 | -12.91 |
| 2024-12-04 | -12.96 |
| 2024-12-03 | -12.82 |
| 2024-12-02 | -13.08 |
| 2024-11-29 | -12.81 |
| 2024-11-27 | -13.06 |
| 2024-11-26 | -12.34 |
| 2024-11-25 | -12.22 |
| 2024-11-22 | -12.21 |
| 2024-11-21 | -12.06 |
| 2024-11-20 | -11.89 |
| 2024-11-19 | -11.46 |
| 2024-11-18 | -11.59 |
| 2024-11-15 | -12.10 |
| 2024-11-14 | -12.75 |
| 2024-11-13 | -13.13 |
| 2024-11-12 | -13.30 |
| 2024-11-11 | -14.15 |
| 2024-11-08 | -13.93 |
| 2024-11-07 | -13.60 |
| 2024-11-06 | -14.28 |
| 2024-11-05 | -13.78 |
| 2024-11-04 | -13.37 |
| 2024-11-01 | -13.36 |
| 2024-10-31 | -13.30 |
| 2024-10-30 | -13.71 |
| 2024-10-29 | -13.58 |
| 2024-10-28 | -13.61 |
| 2024-10-25 | -13.73 |
| 2024-10-24 | -13.86 |
| 2024-10-23 | -13.64 |
| 2024-10-22 | -13.45 |
| 2024-10-21 | -13.35 |
| 2024-10-18 | -13.39 |
| 2024-10-17 | -13.30 |
| 2024-10-16 | -13.26 |
| 2024-10-15 | -12.97 |
| 2024-10-14 | -13.38 |
| 2024-10-11 | -13.81 |
| 2024-10-10 | -13.60 |
| 2024-10-09 | -13.64 |
| 2024-10-08 | -13.46 |
| 2024-10-07 | -13.36 |
| 2024-10-04 | -13.86 |
| 2024-10-03 | -13.31 |
| 2024-10-02 | -13.41 |